Member of the Board
Veterinary and Animal Sciences
Veterinarian
Denmark
Johannes Holst has expertise in developing viral vectored vaccines, genetic adjuvants and animal models. He works at the University of Copenhagen involved in the development of novel vector technologies. An important inspiration has been the technical requirements needed to explore new anti-HIV, which have let to both new T cell and B cell adjuvant technologies. Johannes Holst has expertise in developing viral vectored vaccines, genetic adjuvants and animal models. He works at the University of Copenhagen involved in the development of novel vector technologies. An important inspiration has been the technical requirements needed to explore new anti-HIV, which have let to both new T cell and B cell adjuvant technologies.
virology, vaccination and veterinary sciences